Validity of Self-reported Causes of Subfertility
Author:
Publisher
Oxford University Press (OUP)
Subject
Epidemiology
Link
http://academic.oup.com/aje/article-pdf/161/10/978/245714/kwi120.pdf
Reference22 articles.
1. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol1992;136:1184–203.
2. Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet1999;354:1586–90.
3. Burkman RT, Tang MT, Malone KE, et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril2003;79:844–51.
4. Klip H, van Leeuwen FE, Schats R, et al. Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women. Hum Reprod2003;18:1951–8.
5. Klip H, Burger CW, de Kraker J, et al. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod2001;16:2451–8.
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022;The Lancet Regional Health - Europe;2024-10
2. Reproductive Tract Complications Following Undiagnosed, Asymptomatic and Symptomatic Chlamydia Trachomatis Infections: A Long Term Observational Cohort Study;2024
3. Maternal self-reported polycystic ovary syndrome with offspring and maternal cardiometabolic outcomes;Human Reproduction;2023-11-04
4. Self-reported infertility diagnoses and treatment history approximately 20 years after fertility treatment initiation;Fertility Research and Practice;2021-03-12
5. Female reproductive function after treatment of childhood acute lymphoblastic leukemia;Pediatric Blood & Cancer;2021-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3